← Scoopfeeds — Intelligent news, curated.
Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026
business

Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026

Yahoo Finance · Jun 3, 2026, 6:00 PM

Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026

Read full story on Yahoo Finance → More top stories

More in business

Investing.com
Wheaton Precious Metals launches $1M mining innovation challenge
Bloomberg Markets
Fahmy: Trump Weary of Returning to Obama Era JCPOA
Investing.com
Revolution Beauty FCA investigation closed with no action
Bloomberg Markets
European Gas Set for Weekly Gain With US-Iran Deal Still Elusive
CoinDesk
Bitcoin in danger of dropping to $60,000, with Zcash bulls turning their backs on ZEC
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop